{
  "meta": {
    "source": "synthetic_generator",
    "version": "1.0"
  },
  "data": {
    "detail": {
      "patient": {
        "structured": {
          "age_value__v": 64,
          "weight_value__v": 87.9,
          "gender_value__v": "Male"
        }
      },
      "case_product__v": {
        "structured": [
          {
            "product_name__v": "Atorvastatin",
            "dose__v": "2 tablet(s) daily",
            "indication__v": "culture"
          }
        ]
      },
      "case_adverse_event__v": {
        "structured": [
          {
            "event_reported__v": "Fatigue",
            "outcome__v": "Recovered",
            "serious__v": "Yes",
            "country__v": "DE",
            "onset_idate__v": "2003-12-26"
          },
          {
            "event_reported__v": "Shortness of Breath",
            "outcome__v": "Fatal",
            "serious__v": "Yes",
            "country__v": "GB",
            "onset_idate__v": "1982-11-22"
          },
          {
            "event_reported__v": "Blurred Vision",
            "outcome__v": "Not Recovered",
            "serious__v": "No",
            "country__v": "FR",
            "onset_idate__v": "1983-01-01"
          }
        ]
      },
      "structured": {
        "narrative__v": "Miguel Palmer was prescribed Atorvastatin for resource and later developed fatigue along with other symptoms.",
        "report_type__v": "Other",
        "seriousness_criteria__v": "Death",
        "receipt_method__v": "Email",
        "transmission_type__v": "Initial"
      }
    }
  }
}